Parkinstep: Automated PD Gait and Balance Assessment for Optimizing DBS
NCT ID: NCT02080572
Last Updated: 2015-02-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
22 participants
OBSERVATIONAL
2014-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Deep Brain Stimulation Effects on Gait and Balance in Patients With Parkinson's Disease
NCT02022735
Enhancing Gait Using Alternating-Frequency DBS in Parkinson Disease
NCT05022147
DBS of the MLR for Gait and Balance Disorders in PD Patients
NCT02931097
Study of the Effects of STN-DBS on Gait in Parkinson's Disease.
NCT06418802
Computational Modeling of 60 Hz Subthalamic Nucleus Deep Brain Stimulation for Gait Disorder in Parkinson's Disease
NCT04184791
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Parkinson's Disease with DBS
Individuals with Parkinson's disease and deep brain stimulation will be recruited.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \> 21
* Underwent DBS surgery targeting the subthalamic nucleus (STN)
* Bilateral or midline involvement when "off" DBS/medication state
* Clinical history of gait impairment or freezing of gait
Exclusion Criteria
* Underwent DBS surgery targeting the ventral intermediate (VIM)
* Unable to walk independent of a wheelchair (use of assistive devices, like a cane, is okay for this study)
* Dementia (determined by a neuropsychological assessment).
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospitals Cleveland Medical Center
OTHER
University of Cincinnati
OTHER
National Institute on Aging (NIA)
NIH
Great Lakes NeuroTechnologies Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joseph P Giuffrida, PhD
Role: PRINCIPAL_INVESTIGATOR
Great Lakes NeuroTechnologies
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Cincinnati
Cincinnati, Ohio, United States
University Hospitals of Case Western
Cleveland, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AG033947-03A1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.